Vitamin B12, folate and vitamin B6 support methylation and nervous system function. They are also central to how the body handles homocysteine, an amino acid that can rise as levodopa is metabolised.

This has led to growing interest in whether nutrient monitoring should be part of longer-term Parkinson’s Disease care.

Why this matters

One of the main ways the body breaks down levodopa is through a process called methylation. Homocysteine is a by-product of this process, so more levodopa can mean more homocysteine.

The body clears homocysteine using folate and vitamin B12 to recycle it, and vitamin B6 to convert it into other compounds. Over years of treatment, this extra demand may lower vitamin B12 and folate in some people and allow homocysteine to build up.

Vitamin B6 also deserves attention. Carbidopa, the drug paired with levodopa in many formulations, binds to the active form of vitamin B6, and higher doses can lower vitamin B6 levels.

Raised homocysteine and low vitamin B12 or vitamin B6 have been associated with peripheral neuropathy. This is nerve damage in the hands and feet, which can sometimes be mistaken for an ordinary Parkinson’s Disease symptom rather than recognised as a separate and often treatable complication.

Who may be at greater risk?

Levodopa is not the only factor. Vitamin B12 absorption naturally declines with age, and some common medications, including certain treatments for acid reflux and type 2 diabetes, can reduce it further.

Plant-based diets, reduced appetite, unintended weight loss and digestive problems can all play a part too. When several of these overlap with long-term levodopa, monitoring becomes even more worthwhile.

What can help?

If you are on long-term levodopa, it may be worth having vitamin B12, folate and vitamin B6 status checked regularly, rather than waiting for symptoms. Correcting a genuine deficiency early is usually more straightforward than waiting until problems become established.

What this looks like in practice depends on your diet, medication history and any symptoms already present. It also depends on which markers are tested, and whether dietary changes or supplementation are appropriate.

Diet needs particular care because many foods that provide these nutrients are also rich in protein, which can compete with levodopa for absorption. This is why individual review works better than a standard supplement routine.

Standard blood tests do not always tell the full story. A vitamin B12 result in the normal range can sometimes hide a functional deficiency, which a test called methylmalonic acid, or MMA, may help identify.

Homocysteine can also be useful to track, but in people taking levodopa it rises partly because of the medication itself. This means it needs careful interpretation.

Making changes manageable

If supplementation is recommended, introduce it as a single, deliberate change and let follow-up blood tests guide whether it is working.

More is not better here. Very high intakes of vitamin B6 can themselves cause nerve problems, so dosing should be guided by your results.

Baseline testing before symptoms have a chance to develop is also sensible, because it gives you something to compare with over time.

Understanding the evidence

The link between levodopa and raised homocysteine is well described and is one of the more consistently reproduced findings in Parkinson’s Disease nutrition research.

However, the evidence that correcting these levels prevents or reverses neuropathy is not guaranteed. Even so, there is still a good rationale for monitoring levels and assessing symptom changes carefully.

How I can support you

If you are on long-term levodopa, I can help you understand which nutrient markers may be worth discussing with your healthcare team.

I can also help you review whether your diet supports vitamin B12, folate and vitamin B6 intake where dietary intake is genuinely part of the picture, and whether targeted supplement recommendations may be appropriate.

Final thoughts

Homocysteine, vitamin B12 and vitamin B6 status are worth regular monitoring for anyone on long-term levodopa.

That is not because problems are certain, but because catching a deficiency early is straightforward and worthwhile.